KRN-8602

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameKRN-8602
Drug Alias NameMX-2KRN-8602NSC-619003
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics
Mechanisms of ActionUpdating
TargetsNot applicable
Therapy Area/IndicationsBrain NeoplasmsBreast NeoplasmsLeukemia, Myeloid, Acute +[4
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesKirin Holdings Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesKirin Holdings Co Ltd
Active IndicationsN/A
Inactive IndicationsBrain NeoplasmsBreast NeoplasmsLeukemia, Myeloid, Acute +[4

Other Information

ATC CodeN/A
Related LinksN/A